# Accell Evo3™ Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion

> **NCT02018445** · NA · COMPLETED · sponsor: **SeaSpine, Inc.** · enrollment: 36 (actual)

## Conditions studied

- Degenerative Changes
- Stenosis
- Spondylosis

## Interventions

- **PROCEDURE:** Posterolateral Fusion

## Key facts

- **NCT ID:** NCT02018445
- **Lead sponsor:** SeaSpine, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-07
- **Final completion:** 2017-05
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02018445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02018445, "Accell Evo3™ Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02018445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*